Easier injections for asthma? study tests two delivery methods
NCT ID NCT07701239
First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time
Summary
This study tests whether a prefilled autoinjector delivers the drug SHR-1703 as effectively as a standard prefilled syringe in healthy adults. The goal is to see if the autoinjector provides a similar level of drug in the blood, which could make future injections easier for people with eosinophilic asthma. Participants receive a single dose of SHR-1703 by either method, and researchers compare drug levels and safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SHR-1703 injection
- What this could lead to
- If successful, this could lead to a more convenient way for patients to receive SHR-1703, potentially improving ease of use for asthma treatment.
- What could go wrong
- This is an early-phase study in healthy people, not patients, so results may not directly translate to real-world use or show how well the drug works for asthma.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA WITH EOSINOPHILIC PHENOTYPE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital ， Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310000, China
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.